Patients die in Global Blood Therapeutics study

Two of seven patients in Global Blood Therapeutics Inc. (Nasdaq: GBT) study of voxelotor died. The stock price plummeted $6.38 to close at $38.40.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.